Skip to content

Septerna, Inc. SEPN Additional Paid-In Capital

Additional Paid-In Capital at other companies

Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$942.7M+29.5%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$1.57B+23.2%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$727.05M+67.6%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$2.13B+3.5%
Precigen logo
PrecigenPGEN
$2.37B+11.2%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$489.22M+8.2%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s additional paid-in capital?
Septerna, Inc. (SEPN) reported additional paid-in capital of $554.87M in Q1 2026.
How has Septerna, Inc.'s additional paid-in capital changed year-over-year?
Septerna, Inc.'s additional paid-in capital increased by 2.8% year-over-year, from $539.87M to $554.87M.
What is the long-term trend for Septerna, Inc.'s additional paid-in capital?
Over 2 years (2023 to 2025), Septerna, Inc.'s additional paid-in capital has grown at a 717.9% compound annual growth rate (CAGR), from $8.2M to $548.52M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.